T.Man Pharmaceutical (TMAN) Stock Overview
Manufactures and sells pharmaceuticals and health care products in Thailand. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
TMAN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
T.Man Pharmaceutical Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿11.00 |
| 52 Week High | ฿13.60 |
| 52 Week Low | ฿9.95 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | -15.38% |
| 1 Year Change | -6.78% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -32.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| TMAN | TH Pharmaceuticals | TH Market | |
|---|---|---|---|
| 7D | 1.9% | 7.8% | 4.5% |
| 1Y | -6.8% | 2.7% | 45.1% |
Return vs Industry: TMAN underperformed the TH Pharmaceuticals industry which returned 2.7% over the past year.
Return vs Market: TMAN underperformed the TH Market which returned 45.1% over the past year.
Price Volatility
| TMAN volatility | |
|---|---|
| TMAN Average Weekly Movement | 3.8% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in TH Market | 10.1% |
| 10% least volatile stocks in TH Market | 2.0% |
Stable Share Price: TMAN has not had significant price volatility in the past 3 months compared to the TH market.
Volatility Over Time: TMAN's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | n/a | Prapon Thanachotipan | www.tmanpharmaceutical.com |
T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health care products in Thailand. The company operates through three segments: Manufactured Products Under Own Brand, Manufactured Products Under Third Parties’ Brand, and Trading Products. It offers antibacterial, central nervous system, corticosteroid, chronic diseases, gastrointestinal, respiratory, and musculoskeletal drugs, as well as medical devices, vaginal suppositories, dermatological, mouth, and throat products.
T.Man Pharmaceutical Public Company Limited Fundamentals Summary
| TMAN fundamental statistics | |
|---|---|
| Market cap | ฿4.40b |
| Earnings (TTM) | ฿515.79m |
| Revenue (TTM) | ฿2.56b |
Is TMAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TMAN income statement (TTM) | |
|---|---|
| Revenue | ฿2.56b |
| Cost of Revenue | ฿1.37b |
| Gross Profit | ฿1.19b |
| Other Expenses | ฿676.40m |
| Earnings | ฿515.79m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.29 |
| Gross Margin | 46.56% |
| Net Profit Margin | 20.14% |
| Debt/Equity Ratio | 38.1% |
How did TMAN perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/06 17:46 |
| End of Day Share Price | 2026/07/06 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
T.Man Pharmaceutical Public Company Limited is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Theethanat Jindarat | Yuanta Securities (Thailand) Company Limited |
| Kritawit Ratanakhanokchai | Yuanta Securities (Thailand) Company Limited |
| Athitaya Chinakanjanadit | Yuanta Securities (Thailand) Company Limited |